6-Fluoro-5-(4-((5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl)piperazin-1-yl)-N-methylpicolinamide
98%
- Product Code: 186612
CAS:
2756333-39-6
| Molecular Weight: | 428.44 g./mol | Molecular Formula: | C₂₁H₂₂F₂N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of targeted therapies for solid tumors due to its ability to modulate signaling pathways linked to tumor growth and metastasis. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its fluorinated structure enhances metabolic stability and membrane permeability, making it valuable in designing orally bioavailable agents. Currently investigated in preclinical studies for oncology applications.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $1,207.00 |
+
-
|
| 0.025 | 10-20 days | $2,391.45 |
+
-
|
| 0.005 | 10-20 days | $912.16 |
+
-
|
6-Fluoro-5-(4-((5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl)piperazin-1-yl)-N-methylpicolinamide
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of targeted therapies for solid tumors due to its ability to modulate signaling pathways linked to tumor growth and metastasis. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its fluorinated structure enhances metabolic stability and membrane permeability, making it valuable in designing orally bioavailable agents. Currently investigated in preclinical studies for oncology applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :